When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMF - FibroGen up 16% as safety concerns with roxadustat ebb
Astellas Pharma Inc
FibroGen (FGEN+15.6%) rallies on a 6x surge in volume on the heels of safety data on lead drug roxadustat. Pooled results from six Phase 3 studies evaluating the candidate for the treatment of anemia in CKD patients showed a safety profile comparable to placebo, putting investors at ease over the issue.
More news on: FibroGen, Inc., AstraZeneca PLC, Astellas Pharma Inc., Healthcare stocks news, Stocks on the move,